AI Verdict
IMAX has stronger fundamentals based on our AI analysis.
IMAX vs IMA Fundamental Comparison
| Metric | IMAX | IMA |
|---|---|---|
| Revenue | $410.2M | $800,000.0 |
| Net Income | $34.9M | $-45.3M |
| Net Margin | 8.5% | -5,668.6% |
| ROE | 10.3% | -34.1% |
| ROA | 3.9% | -29.6% |
| Current Ratio | N/A | 12.49x |
| Debt/Equity | 0.00x | 0.00x |
| EPS | $0.63 | $-9.64 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
IMAX vs IMA: Frequently Asked Questions
Is IMAX or IMA a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), IMAX has stronger fundamentals. IMAX is rated HOLD (78% confidence) while IMA is rated STRONG SELL (85% confidence). This is not investment advice.
How does IMAX compare to IMA fundamentally?
IMAX CORP has ROE of 10.3% vs ImageneBio, Inc.'s -34.1%. Net margins are 8.5% vs -5,668.6% respectively.
Which stock pays higher dividends, IMAX or IMA?
IMAX has a dividend yield of N/A or no dividend while IMA has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in IMAX or IMA for long term?
For long-term investing, consider that IMAX has HOLD rating with 78% confidence, while IMA has STRONG SELL rating with 85% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about IMAX vs IMA?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For IMAX vs IMA, the AI consensus favors IMAX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.